Scinai Immunotherapeutics (SCNI) Interest Expenses (2014 - 2025)
Scinai Immunotherapeutics (SCNI) reported Interest Expenses of $12000.0 for Q4 2025, down 99.13% on a YoY basis from $1.4 million in Q4 2024, and down 99.13% sequentially from $1.4 million in Q4 2024.
Scinai Immunotherapeutics (SCNI) Interest Expenses (2014 - 2025) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 12 years of Interest Expenses data on file, last reported at $12000.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses fell 99.13% year-over-year to $12000.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (changed 0.0% YoY), and the FY2025 full-year result was $28.5 million, up 20.33% from the prior year.
- Interest Expenses retreated to $12000.0 in Q4 2025, from $1.4 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $3.4 million in Q4 2022 to a low of -$3.6 million in Q2 2022.
- A 5-year average of -$169153.8 and a median of $108000.0 in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses tumbled 25658.33% in 2021 and jumped 1171.3% in 2024, its largest moves.
- Tracing SCNI's Interest Expenses over 5 years: stood at $490000.0 in 2021, then soared by 604.08% to $3.4 million in 2022, then slumped by 96.87% to $108000.0 in 2023, then jumped by 1171.3% to $1.4 million in 2024, then slumped by 99.13% to $12000.0 in 2025.
- Business Quant data shows SCNI's Interest Expenses at $12000.0 in Q4 2025, $1.4 million in Q4 2024, and $143000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 1.37 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Mar 31, 2024 | 143,000.00 |
| Mar 31, 2024 | 143,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Mar 31, 2023 | 725,000.00 |
| Mar 31, 2023 | 725,000.00 |
| Dec 31, 2022 | 3.45 Mn |
| Dec 31, 2022 | 3.45 Mn |
| Sep 30, 2022 | 2.56 Mn |
| Sep 30, 2022 | 2.56 Mn |
| Jun 30, 2022 | -3.64 Mn |
| Jun 30, 2022 | -3.64 Mn |
| Mar 31, 2022 | -737,000.00 |
| Mar 31, 2022 | -737,000.00 |
| Dec 31, 2021 | 490,000.00 |
| Dec 31, 2021 | 490,000.00 |